HASEGAWA Kosei

Affiliation and department：
Job title： Professor
Homepage URL (1)： http://www.saitama-med.ac.jp/kokusai/fujinshuyo/
Research theme for competitive and other funds (6)：

2016 - 現在卵巣明細胞腺癌におけるネオ抗原および局所免疫応答の統合的解析
2019 - 2023 卵巣癌の個別化治療を目指した免疫プロファイルに基づく包括的バイオマーカーの開発
2020 - 2021 ヒト上皮性腫瘍の発生・進展機構の解明と新規治療標的の同定
2018 - 2021 卵巣癌における、低酸素関連因子の発現からみた組織型の意義:科学療法抵抗性の分別化
2020 - 抗レトロウィルス薬のドラッグリバーバシングによるLINE1発現子宮体癌の治療戦略

Show all

Papers (79)：

Takeda A, Kobayashi M, Hasegawa K, Fujimaki T. Cancer Susceptibility Gene 1 (BRCA1) Germline Mutation. Cureus. Cureus. 2023
Yonemori K, Yunokawa M, Ushijima K, Sakata J, Shikama A, Minobe S, Usami T, Enomoto T, Takehara K, Hasegawa K, et al. Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775. Cancer Science. 2022. 3489-3497
Nishio S, Yonemori K, Usami T, Minobe S, Yunokawa M, Iwata T, Okamoto A, Aoki Y, Itamochi H, Takekuma M, et al. Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826. Cancer Science. 2022. 3877-3887
Yonemori K, Kuboki Y, Hasegawa K, Iwata T, Kato H, Takehara K, Hirashima Y, Kato H, Passey C, Buchbjerg JK, et al. Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study. Cancer Science. 2022. 2788-2797
Sato S, Matsushita H, Shintani D, Kobayashi Y, Fujieda N, Yabuno A, Nishikawa T, Fujiwara K, Kakimi K, Hasegawa K. Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer. BMC Cancer. 2022

ｍore...

Lectures and oral presentations (24)：

HDAC6 as a therapeutic target for ovarian clear cell carcinoma, in association with ARID1A loss
(17th Biennial Meeting of the International Gynecologic Cancer Society 2018)
Soluble folate receptor alpha as a biomarker for epithelial ovarian cancer
(72th Japanese Cancer Association 2013)
Redirected antitumor activity of an engineered Sendai virus vector in ovarian cancer cells
(AACR/JCA 2013)
Tumor Board I: Clear cell carcinoma of the uterus
(14th Biennial Meeting of the International Gynecologic Cancer Society 2012)
Soluble MUC1 as a Biomarker for Epithelial Ovarian Cancer
(14th Biennial Meeting of the International Gynecologic Cancer Society 2012)

ｍore...

Education (2)：

2000 - 2004 Okayama University Graduate School, Division of Medicine
1991 - 1997 Okayama University Graduate School, Division of Medicine

Professional career (2)：

医学士 (岡山大学)
医学博士 (岡山大学大学院)

Work history (8)：

2006/10 - 2008/09 University of Pennsylvania Ovarian Cancer Research Center Researher Postdoc
2006/10 - 2008/09 University of Pennsylvania Ovarian Cancer Research Center Researcher
2006/10 - 2008/09 University of Pennsylvania Ovarian Cancer Research Center Researcher
2004/09 - 2006/09 Mayo Clinic Department of Molecular Medicine Researher Postdoc
2004/09 - 2006/09 Mayo Clinic Department of Molecular Medicine Researcher

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page